OSX2:XETRA:XETRA-Ossiam US Minimum Variance ESG NR UCITS ETF 1A (EUR) EUR (EUR)

ETF | Others |

Last Closing

USD 321.65

Change

+1.50 (+0.47)%

Market Cap

N/A

Volume

31.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.62 (+1.33%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.24 (+0.23%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.25 (+1.04%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.16 (+1.20%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.07 (+1.24%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.20 (+0.84%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

N/A

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.30 (+0.55%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.09 (+0.89%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.16 (-0.13%)

USD 12.26B

ETFs Containing OSX2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.63% 74% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.63% 74% C 68% D+
Trailing 12 Months  
Capital Gain 19.77% 82% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.77% 82% B 78% C+
Trailing 5 Years  
Capital Gain 55.16% 62% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 55.16% 62% D 62% D
Average Annual (5 Year Horizon)  
Capital Gain 9.76% 62% D 62% D
Dividend Return 9.76% 61% D- 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.91% 63% D 71% C-
Risk Adjusted Return 98.52% 83% B 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike